A month has gone by since the last earnings report for Accuray (ARAY) . Shares have added about 1.6% in that time frame, underperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Accuray due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts. Accuray Q2 Earnings Lag Estimates, Gross Margin Contracts ...

Company to Take Part in Fireside Chat Tuesday, March 12, 2024 at 7:00am PST / 10:00am EST MADISON, Wis., Feb. 27, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference taking place March 12-13, 2024. The management team is scheduled to participate in a fireside chat on Tuesday, March 12, 2024 at 7:00am PST / 10:00am EST. A live webcast of the fireside chat can be accessed on the Accuray website at in ...

While most financial advisors will probably steer you away from under $5 stocks, they have their benefits. Just like in football – the American kind – you can’t just run up the gut.Well, technically, you can. That’s where the phrase three yards and a cloud of dust basically originated. If you hold onto the ball and keep marching down the field, you eat up the clock and deny opportunities to your opposition. However, the problem with this rather unimaginative strategy is that stuff happens.And that stuff – t ...

Accuray Incorporated (ARAY) is well-poised for growth in the coming quarters, courtesy of continued solid demand for its products. The optimism led by the second quarter of fiscal 2024 performance and potential in Precision Treatment Planning System (TPS) are expected to contribute further. However, overdependence on technologies and stiff competition persists.Over the past year, this Zacks Rank #3 (Hold) stock has lost 5.8% against the 9.3% rise of the industry. The S&P 500 has witnessed 25.4% growth in th ...

Montérégie Integrated Cancer Center, part of Charles-LeMoyne Hospital, is a center of excellence and recognized leader in the treatment of cancer in the province of Quebec The Radixact System is equipped with ClearRT™ and Synchrony®, advanced technologies designed to improve treatment outcomes for more patients each day MADISON, Wis., Feb. 13, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the team at Quebec's Montérégie Integrated Cancer Center, part of Charles-LeMoyne Hosp ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 par value per share ARAY The Nasdaq Stock Market LLC FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commissio ...

MADISON, Wis., Feb. 5, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place on February 13, 2024. BTIG-hosted events are intended for prospective and existing BTIG clients only. To request a one-on-one meeting with management, please contact your BTIG representative with interest. About AccurayAccuray is committed to expanding the powerful potential of radiation therapy to ...

Accuray Incorporated (ARAY) reported loss per share of 10 cents for the second quarter of fiscal 2024, wider than the year-ago period’s loss of 2 cents per share. The metric was also wider than the Zacks Consensus Estimate of a loss of 7 cents per share.Revenues in DetailAccuray registered revenues of $107.2 million in the second quarter of fiscal 2024, down 6.6% year over year. The figure, however, topped the Zacks Consensus Estimate by 0.1%.The overall top-line growth was dampened by lower Products revenu ...

Accuray Incorporated (NASDAQ:ARAY) Q2 2024 Earnings Conference Call January 31, 2024 4:30 PM ET Company Participants Jesse Chew - Senior Vice President, Chief Legal Officer Suzanne Winter - Chief Executive Officer Ali Pervaiz - Senior Vice President and Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Brooks O'Neil - Lake Street Capital Markets Operator Good day, and welcome to the Accuray Second Quarter Fiscal 2024 Financial Results. All participants will be in listen-only mode. [ ...

Accuray (ARAY) reported $107.24 million in revenue for the quarter ended December 2023, representing a year-over-year decline of 6.6%. EPS of -$0.10 for the same period compares to -$0.02 a year ago.The reported revenue represents a surprise of +0.12% over the Zacks Consensus Estimate of $107.11 million. With the consensus EPS estimate being -$0.07, the EPS surprise was -42.86%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall St ...